Salomon M. Stemmer

19.4k citations
237 papers · 8.5k indexed · 2 hit papers · h-index 46
Topics
Advanced Breast Cancer Therapies (33 papers)Cancer Treatment and Pharmacology (33 papers)HER2/EGFR in Cancer Research (30 papers)

In The Last Decade

Salomon M. Stemmer

228 papers receiving 8.3k citations

Hit Papers

Olaparib Monotherapy in Patients With Advanced Cancer and...2011202620162021201420114008001.2k

Peers

Salomon M. Stemmer
Comparison fields: 5 of 143
  • Oncology 5.0k
  • Molecular Biology 2.0k
  • Cancer Research 1.7k
  • Pulmonary and Respiratory Medicine 1.6k
  • Reproductive Medicine 926
Replace Jan B. Vermorken with:
Jan B. Vermorken Belgium
Marianne Paesmans Belgium
Judith R. Kroep Netherlands
Christian Marth Austria
Diana Giannarelli Italy
Malcolm D. Mason United Kingdom
Anthony F. Shields United States
D. Wallwiener Germany
Walter M. Gregory United Kingdom
Tanja Fehm Germany
Salomon M. Stemmer relative to Jan B. Vermorken Belgium Jan B. Vermorken's profile →
Citations per field
00.5×1.5×
Jan B. Vermorken · 1×
Citations per year

Countries citing papers authored by Salomon M. Stemmer

Since Specialization
Citations

This map shows the geographic impact of Salomon M. Stemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salomon M. Stemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salomon M. Stemmer more than expected).

Fields of papers citing papers by Salomon M. Stemmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salomon M. Stemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salomon M. Stemmer. The network helps show where Salomon M. Stemmer may publish in the future.

Co-authorship network of co-authors of Salomon M. Stemmer

This figure shows the co-authorship network connecting the top 25 collaborators of Salomon M. Stemmer. A scholar is included among the top collaborators of Salomon M. Stemmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salomon M. Stemmer. Salomon M. Stemmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 0
4 1
5 1
6 2
7 1
8 5
9 4
10 71
11 16
12 113
13 10
14 21
15 24
16 298
17 1
18 76
19
CF102 an A3 adenosine receptor agonist induces in vivo apoptosis of Hepatocellular carcinoma
0
20 7

About Salomon M. Stemmer

Salomon M. Stemmer is a scholar working on Oncology, Physiology and Cancer Research, having authored 237 papers that have together received 8.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (33 papers), Cancer Treatment and Pharmacology (33 papers) and HER2/EGFR in Cancer Research (30 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (1.7k citations) and Reproductive Medicine (926 citations). Salomon M. Stemmer has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Irit Ben‐Aharon, Bella Kaufman, Georgeta Fried, Ora Rosengarten, Susan M. Domchek, Ayala Hubert, Ronnie Shapira‐Frommer, Judith Balmañà, Michael Friedländer and Gillian Mitchell. Their work appears in journals such as Cell, JAMA and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026